News and Media

PolyPhotonix awarded first ever SBRI Healthcare phase 3 programme

PolyPhotonix have recently signed a contract with SBRI Healthcare to undertake Phase 3 SBRI funding for the treatment of Diabetic Retinopathy using their Noctura 400® sleep mask. The programme awarded to PolyPhotonix is the first ever example of Phase 3 SBRI funding in England and provides a crucial patient care pathway to speed up the adoption of PolyPhotonix’s treatment method for Diabetic Retinopathy.

Read the article →